1.06-5 Spa therapy and rheumatoid arthritis - Quality of life
Isabel SANTOS ; Oscar RIBEIRO ; Claudia RIBEIRO ; Pedro CANTISTA ; Carlos VASCONCELOS
The Journal of The Japanese Society of Balneology, Climatology and Physical Medicine 2014;77(5):471-472
Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory disorder of unknown etiology. It is characterized by symmetric, polyarticular pain, swelling, morning stiffness, and fatigue. RA has a variable course, often with periods of exacerbations and, less frequently, true remissions. Outcomes are also variable, ranging from the rarely seen remitting disease to severe disease that brings disability and in some patients premature death. Without treatment, the majority of patients will experience progressive joint damage and, in some patients, this results in significant disability within just a few years. Improvement in health related quality of life is one of the most important goals in the management of rheumatoid arthritis and therefore must be pursued as a crucial aim in clinical practice. This paper draws from 49 qualitative interviews conducted with RA patients, before starting a program of Spa Therapy and aims to get an overview of their main RA related difficulties, worries, and overall understanding of quality of life. Information on the patients’ physical function was also obtained by means of the Stanford Health Assessment Questionnaire Disability Index (HAQ). Patients present a mean HAQ score of 1.42 (SD=0.69). Main findings from the interviews highlight the importance given to being autonomous and feeling independent and healthy. In addition, underlying psychological problems (e.g. depressive signs; coping with progressive dependence) and concerns with social relationships (e.g. perceived support, loneliness) emerged as significant facets of living with the disease. Despite different treatments, RA still has many deleterious consequences which from the patients’ perspective include, among other, persistent pain, functional disability, fatigue, and depression. Along with treating RA signs and associated medical evolution, medical staff should consider and deeply understand the patients’ needs, expectations and main perceived determinants of their quality of life.
2. Parsonage-Turner syndrome following chikungunya virus infection: A case report
Luis Arthur Brasil Gadelha FARIAS ; Roberto Da Justa PIRES NETO ; Jorge Luiz Nobre RODRIGUES ; Marina Vasconcelos SAMPAIO ; Antônio Carlos Delgado SAMPAIO ; Roberto Da Justa PIRES NETO ; Jorge Luiz Nobre RODRIGUES
Asian Pacific Journal of Tropical Medicine 2019;12(5):239-243
Rationale: Parsonage-Turner syndrome is a rare syndrome of unknown etiology, affecting mainly the lower motor neurons of the brachial plexus. Chikungunya fever is a mosquito-borne viral disease characterized by acute fever and polyarthritis/polyarthralgia. Patient concerns: A 54-year-old Brazilian male patient who presented with a 2-day history of fever (temperature 38.8 °C), arthralgia, erythematous rash, diffuse osteomuscular pain and headache, which evolved into left shoulder pain associated with morning stiffness. Diagnosis: Parsonage-Turner syndrome and chikungunya fever. Interventions: Symptomatic treatment (a combination of short-acting dypirone (500 mg every 6 h) and slow-release opioids (tramadol 100 mg every 4 h) and physiotherapy/rehabilitation with improvement. Outcomes: The patient was improved and discharged, remaining with symptomatic treatment and physiotherapy/rehabilitation. Lessons: To the best of our knowledge, there were no reports of Parsonage-Turner syndrome following chikungunya virus infection. Awareness of the possibility of this rare association is important. The present case report highlights the importance of awareness of this association as a new cause of morbidity in patients with chikungunya virus infection.
3.Erratum: Tolerogenic Dendritic Cells Reduce Airway Inflammation in a Model of Dust Mite Triggered Allergic Inflammation.
Luciana Souza DE ARAGÃO-FRANÇA ; Viviane Costa Junqueira ROCHA ; Andre CRONEMBERGER-ANDRADE ; Fábio Henrique Brasil DA COSTA ; Juliana Fraga VASCONCELOS ; Daniel Abensur ATHANAZIO ; Daniela Nascimento SILVA ; Emanuelle Souza SANTOS ; Cássio Santana MEIRA ; Cintia Figueiredo ARAUJO ; Jéssica Vieira CERQUEIRA ; Daniela Nascimento SILVA ; Fabíola CARDILLO ; Neuza Maria ALCÂNTARA-NEVES ; Milena Botelho Pereira SOARES ; Lain Carlos PONTES DE CARVALHO
Allergy, Asthma & Immunology Research 2018;10(6):724-725
This erratum is being published to correct the printing error on page 406 of the article. Corrections for author names are needed.